$119.01
-2.29[-1.89%]
Last update: 3:14PM Get Real Time Here
Zimmer Biomet Holdings
(NYSE:ZBH)Zimmer Biomet Holdings Stock (NYSE:ZBH), Analyst Ratings, Price Targets, Predictions
Zimmer Biomet Holdings Inc has a consensus price target of $126.83, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Evercore ISI Group, Citigroup, and Canaccord Genuity on April 4, 2024, April 3, 2024, and February 23, 2024. With an average price target of $133.33 between Evercore ISI Group, Citigroup, and Canaccord Genuity, there's an implied 10.19% upside for Zimmer Biomet Holdings Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Evercore ISI Group
Citigroup
Canaccord Genuity
Barclays
Truist Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Zimmer Biomet Holdings
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/04/2024 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 7.44% | Evercore ISI Group | Vijay Kumar | $125 → $130 | Maintains | In-Line | Get Alert |
| 04/03/2024 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 15.7% | Citigroup | Joanne Wuensch | $134 → $140 | Maintains | Neutral | Get Alert |
| 02/23/2024 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 7.44% | Canaccord Genuity | Caitlin Cronin | → $130 | Reiterates | Hold → Hold | Get Alert |
| 02/12/2024 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 7.44% | Barclays | Matt Miksic | $120 → $130 | Maintains | Underweight | Get Alert |
| 02/09/2024 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 11.57% | Truist Securities | Richard Newitter | $133 → $135 | Maintains | Hold | Get Alert |
| 02/09/2024 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 3.31% | JP Morgan | Robbie Marcus | $115 → $125 | Maintains | Neutral | Get Alert |
| 02/09/2024 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 15.7% | RBC Capital | Shagun Singh | → $140 | Reiterates | Outperform → Outperform | Get Alert |
| 01/12/2024 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 15.7% | RBC Capital | Shagun Singh | $134 → $140 | Maintains | Outperform | Get Alert |
| 01/04/2024 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 3.31% | Evercore ISI Group | Vijay Kumar | $135 → $125 | Downgrade | Outperform → In-Line | Get Alert |
| 01/03/2024 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 13.22% | Raymond James | Jayson Bedford | $133 → $137 | Maintains | Outperform | Get Alert |
| 12/22/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 9.92% | Truist Securities | Richard Newitter | $115 → $133 | Maintains | Hold | Get Alert |
| 12/04/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 3.31% | Morgan Stanley | Cecilia Furlong | $120 → $125 | Maintains | Equal-Weight | Get Alert |
| 11/13/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 15.7% | JMP Securities | David Turkaly | $160 → $140 | Maintains | Market Outperform | Get Alert |
| 11/09/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 9.92% | Raymond James | Jayson Bedford | $160 → $133 | Maintains | Outperform | Get Alert |
| 11/08/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | -0.83% | Morgan Stanley | Cecilia Furlong | $140 → $120 | Maintains | Equal-Weight | Get Alert |
| 11/08/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | -4.96% | JP Morgan | Robbie Marcus | $146 → $115 | Maintains | Neutral | Get Alert |
| 10/20/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | -0.83% | Roth MKM | Jason Wittes | → $120 | Initiates | → Neutral | Get Alert |
| 10/02/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 3.31% | Citigroup | Joanne Wuensch | $146 → $125 | Maintains | Neutral | Get Alert |
| 08/28/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $121.00 | 14.88% | BTIG | Ryan Zimmerman | → $139 | Upgrade | Neutral → Buy | Get Alert |
FAQ
What is the target price for Zimmer Biomet Holdings (ZBH)?
The latest price target for Zimmer Biomet Holdings (NYSE: ZBH) was reported by Evercore ISI Group on April 4, 2024. The analyst firm set a price target for $130.00 expecting ZBH to rise to within 12 months (a possible 9.23% upside). 42 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zimmer Biomet Holdings (ZBH)?
The latest analyst rating for Zimmer Biomet Holdings (NYSE: ZBH) was provided by Evercore ISI Group, and Zimmer Biomet Holdings maintained their in-line rating.
When was the last upgrade for Zimmer Biomet Holdings (ZBH)?
The last upgrade for Zimmer Biomet Holdings Inc happened on August 28, 2023 when BTIG raised their price target to $139. BTIG previously had a neutral for Zimmer Biomet Holdings Inc.
When was the last downgrade for Zimmer Biomet Holdings (ZBH)?
The last downgrade for Zimmer Biomet Holdings Inc happened on January 4, 2024 when Evercore ISI Group changed their price target from $135 to $125 for Zimmer Biomet Holdings Inc.
When is the next analyst rating going to be posted or updated for Zimmer Biomet Holdings (ZBH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zimmer Biomet Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zimmer Biomet Holdings was filed on April 4, 2024 so you should expect the next rating to be made available sometime around April 4, 2025.
Is the Analyst Rating Zimmer Biomet Holdings (ZBH) correct?
While ratings are subjective and will change, the latest Zimmer Biomet Holdings (ZBH) rating was a maintained with a price target of $125.00 to $130.00. The current price Zimmer Biomet Holdings (ZBH) is trading at is $119.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.